Enhancement of biological functioning by the use of electromagnetic and magnetic fields

• US 9,737,725 B2
• Filed: 01/17/2014
• Issued: 08/22/2017
• Est. Priority Date: 08/10/2007
• Status: Expired due to Fees

• Current Assignee: Mark Busier
• Original Assignee: Elizabeth A. Rauscher
• Inventors: Rauscher, Elizabeth A.
• Primary Examiner(s): DOUGHERTY, SEAN PATRICK
• Application Number:
  US14/158,304
• Publication Number:
  US 20140135566A1
• Time in Patent Office: 1,313 Days
• CPC Class Codes: A61B 5/40 Detecting, measuring or recording for evaluating the nervous system A61B5/4806, A61B5/4821, A61B5/4824 take precedence
• CPC Class Codes: A61N 1/326 for promoting growth of cells, e.g. bone cells
• CPC Class Codes: A61N 2/004 specially adapted for a specific therapy
• CPC Class Codes: A61N 2/008 for pain treatment or analgesia
• CPC Class Codes: A61N 2/02 using magnetic fields produced by coils, including single turn loops or electromagnets A61N2/12 takes precedence

Abstract

Apparatuses, systems and methods of treating a vertebrate organism via application of signals in a manner that enhances biological function. The signals applied can be produced by an electronic circuit, and can comprise magnetic fields emitted via one or more coil emitter devices.

Claims

1. A method of treating a vertebrate organism, comprising:

using at least one electronic circuit to produce a first signal having a first frequency, and a second signal having a second frequency that is different from the first frequency;

using a first device having a positive direct current bias and coupled to the electronic circuit to target the first and second signals to a first portion of the organism in a manner that the signals are superimposed, and received at the first portion at physiologically acceptable intensities and duty cycles such that the signals entrain a first target tissue of the organism;

wherein the first portion comprises brain tissue; and

using a second device having a negative direct current bias and coupled to the electronic circuit to target the first and second signals to a second portion of the organism different from the first portion in a manner that the signals are superimposed, and received at the second portion at physiologically acceptable intensities and duty cycles such that the signals entrain a second target tissue of the organism.

2. The method of claim 1, wherein the vertebrate organism is a human.

3. The method of claim 1, wherein the first and second signals are selected to produce a plurality of intermodulated additional signals.

4. The method of claim 1, wherein the devices emit the first and second signals as a magnetic field.

5. The method of claim 1, wherein the devices emit the first and second signals as electromagnetic fields.

6. The method of claim 1, wherein the second frequency is selected from the list consisting of 7.6 Hz +/−

2 Hz., 70.25 Hz +/−

0.25 Hz, 71.25 Hz +/−

0.25 Hz, and 3040 Hz +/−

10 Hz.

7. The method of claim 1, wherein the first device and second device compose a multi-coil array.

8. The method of claim 1, further comprising applying the first and second signals for a duration of time sufficient to enhance relaxation and sleep.

9. The method of claim 1, further comprising targeting the first and second signals to affect Purkinje cells of the living being, and wherein the first frequency is 3.2 Hz +0.6/−

0.1 Hz.

10. The method of claim 1, wherein the steps of using the first device and using the second device occur concurrently.

11. The method of claim 1, wherein the first frequency is 3.2 Hz +0.6/−

0.1 Hz, and is applied at an approximately 50% duty cycle.

12. The method of claim 1, wherein the second frequency is 3040 Hz +/−

10 Hz, and is applied at an approximately 25% duty cycle.

13. The method of claim 1, wherein the first target tissue is brain tissue, and wherein the first frequency is 9.41 +/−

2 Hz.

14. The method of claim 1, further comprising administering the first and second signals to enhance sleep, and wherein the first frequency is 3.2 Hz +0.6/−

0.1 Hz.

15. The method of claim 1, further comprising using at least one of the first and second devices to target at least one of the first and second target tissues with a third signal having a third frequency, wherein none of the first, second and third signals is phase locked in the tissue.

16. The method of claim 15, wherein the first frequency is 3.2 Hz +0.6/−

0.1 Hz , the second frequency is 3040 Hz +/−

10 Hz, and the third frequency is 9.41 +/−

2 Hz.

17. The method of claim 1, wherein the first frequency is 3.2 Hz +0.6/−

0.1 Hz and is applied at a duty cycle between 25-50%.

18. The method of claim 1, wherein the second frequency is 3040 Hz +/−

10 Hz, and is applied at an approximately 33.3% duty cycle.

19. The method of claim 1, further comprising applying the first and second signals for a duration of time and at frequencies sufficient to induce a biochemical process that enhances relaxation and sleep.

20. The method of claim 19, wherein the biochemical process comprises producing at least one of a Serotonin and a Dopamine.